Validity of Using Cancer Registry Data in Comparative Effectiveness Research Involving Radiation Therapy

Randomized clinical trials represent the gold standard in comparative effectiveness research, yet many clinical scenarios lack randomized data therefore turning researchers to analyses using other data sources. A large body of comparative effectiveness research uses cancer registry data to compare survival among different treatments. However, the non-randomized nature of these analyses is subject to potential confounding and selection bias. The...